Rung, J., Cauchi, S., Albrechtsen, A., Shen, L., Rocheleau, G., Cavalcanti-Proença, C., Bacot, F., Balkau, B., Belisle, A., Borch-Johnsen, K., Charpentier, G., Dina, C., Durand, E., Elliott, P., Hadjadj, S., Järvelin, M.-R., Laitinen, J.
, Lauritzen, T., Marre, M. ... Sladek, R. (2009).
Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.
Nature Genetics,
41(10), 1110-5.
https://doi.org/10.1038/ng.443
Russell-Jones, D., Vaag, A.
, Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R. & Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group (2009).
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.
Diabetologia,
52(10), 2046-55.
https://doi.org/10.1007/s00125-009-1472-y